Variant report
Variant | esv3333286 |
---|---|
Chromosome Location | chr12:34300670-34310512 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:12)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:12 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr12:34306824-34306969 | IMR90 | lung: | n/a | n/a |
2 | CTCF | chr12:34304060-34304210 | GM12873 | blood: | n/a | n/a |
3 | CTCF | chr12:34300560-34300710 | GM12873 | blood: | n/a | n/a |
4 | CTCF | chr12:34300540-34300690 | AoAF | blood vessel: | n/a | n/a |
5 | FOS | chr12:34300466-34300712 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | MYC | chr12:34304179-34304231 | GM12878 | blood: | n/a | n/a |
7 | POLR2A | chr12:34307379-34307556 | GM12878 | blood: | n/a | n/a |
8 | POLR2A | chr12:34304142-34304260 | A549 | lung: | n/a | n/a |
9 | POLR2A | chr12:34306450-34306529 | A549 | lung: | n/a | n/a |
10 | RFX5 | chr12:34300511-34300733 | GM12878 | blood: | n/a | n/a |
11 | RFX5 | chr12:34305062-34305077 | K562 | blood: | n/a | n/a |
12 | USF2 | chr12:34300561-34300704 | K562 | blood: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ALG10-2 | chr12:34309116-34309255 | ENSG00000255628 |
2 | lnc-ALG10-2 | chr12:34302774-34303105 | ENSG00000255628 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000256986 | TF binding region |
ENSG00000255628 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76138113 | chr12:34300676-34300677 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs557985830 | chr12:34300689-34300690 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs78678973 | chr12:34300690-34300691 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs188514474 | chr12:34300703-34300704 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs533927527 | chr12:34300704-34300705 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs181461124 | chr12:34300709-34300710 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs555223836 | chr12:34302785-34302786 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs149852109 | chr12:34302799-34302800 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs369096839 | chr12:34302803-34302804 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs181656618 | chr12:34302847-34302848 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs186235403 | chr12:34302925-34302926 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs577419157 | chr12:34302959-34302960 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs191017036 | chr12:34302960-34302961 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs372342679 | chr12:34302968-34302969 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs558662825 | chr12:34302973-34302974 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs553131985 | chr12:34303044-34303045 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs181925724 | chr12:34303058-34303059 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs571082916 | chr12:34304016-34304017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540007149 | chr12:34304020-34304021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546842859 | chr12:34304061-34304062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566975439 | chr12:34304072-34304073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573004609 | chr12:34304096-34304097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148252601 | chr12:34304118-34304119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555385064 | chr12:34304132-34304133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs575233269 | chr12:34304173-34304174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536979968 | chr12:34304181-34304182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114696295 | chr12:34304219-34304220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577030080 | chr12:34304243-34304244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73096217 | chr12:34304285-34304286 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs529906856 | chr12:34304289-34304290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs56295970 | chr12:34304384-34304385 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs572904944 | chr12:34304387-34304388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4931799 | chr12:34304443-34304444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192316333 | chr12:34304549-34304550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4244868 | chr12:34304552-34304553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536120685 | chr12:34304584-34304585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34018241 | chr12:34304603-34304604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561712992 | chr12:34304623-34304624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73313395 | chr12:34304632-34304633 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs139719113 | chr12:34304652-34304653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551328768 | chr12:34304698-34304699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564783247 | chr12:34304713-34304714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569992884 | chr12:34304746-34304747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73096221 | chr12:34304750-34304751 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs547172463 | chr12:34304751-34304752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73096224 | chr12:34304760-34304761 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs377696755 | chr12:34304783-34304784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184741344 | chr12:34304789-34304790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74754534 | chr12:34304876-34304877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369653348 | chr12:34304877-34304878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chordoma | 18071362 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:34304000-34304400 | Enhancers | Ovary | ovary |
2 | chr12:34304400-34308800 | Weak transcription | Aorta | Aorta |